1. Home
  2. EVO vs ATRC Comparison

EVO vs ATRC Comparison

Compare EVO & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • ATRC
  • Stock Information
  • Founded
  • EVO 1993
  • ATRC 2000
  • Country
  • EVO Germany
  • ATRC United States
  • Employees
  • EVO N/A
  • ATRC N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • ATRC Medical/Dental Instruments
  • Sector
  • EVO Health Care
  • ATRC Health Care
  • Exchange
  • EVO Nasdaq
  • ATRC Nasdaq
  • Market Cap
  • EVO 1.6B
  • ATRC 1.6B
  • IPO Year
  • EVO 2021
  • ATRC 2005
  • Fundamental
  • Price
  • EVO $3.31
  • ATRC $31.83
  • Analyst Decision
  • EVO Buy
  • ATRC Strong Buy
  • Analyst Count
  • EVO 2
  • ATRC 10
  • Target Price
  • EVO $5.90
  • ATRC $48.50
  • AVG Volume (30 Days)
  • EVO 115.7K
  • ATRC 649.9K
  • Earning Date
  • EVO 05-21-2025
  • ATRC 04-30-2025
  • Dividend Yield
  • EVO N/A
  • ATRC N/A
  • EPS Growth
  • EVO N/A
  • ATRC N/A
  • EPS
  • EVO N/A
  • ATRC N/A
  • Revenue
  • EVO $866,665,179.00
  • ATRC $465,307,000.00
  • Revenue This Year
  • EVO $3.70
  • ATRC $14.60
  • Revenue Next Year
  • EVO $10.32
  • ATRC $12.66
  • P/E Ratio
  • EVO N/A
  • ATRC N/A
  • Revenue Growth
  • EVO N/A
  • ATRC 16.55
  • 52 Week Low
  • EVO $2.85
  • ATRC $18.94
  • 52 Week High
  • EVO $7.98
  • ATRC $43.11
  • Technical
  • Relative Strength Index (RSI)
  • EVO 30.48
  • ATRC 35.29
  • Support Level
  • EVO $3.38
  • ATRC $32.10
  • Resistance Level
  • EVO $3.63
  • ATRC $35.63
  • Average True Range (ATR)
  • EVO 0.10
  • ATRC 1.63
  • MACD
  • EVO -0.00
  • ATRC -0.03
  • Stochastic Oscillator
  • EVO 14.94
  • ATRC 7.54

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

Share on Social Networks: